IVD Study Designs Warrant Consultation With CDRH Staff – Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
Discrepant resolution alone is an inadequate method for reliably estimating the value of a new diagnostic test in relation to an imperfect standard, an FDA draft guidance states